US20180098699A1 - Implanted sensor processing system and method for processing implanted sensor output - Google Patents
Implanted sensor processing system and method for processing implanted sensor output Download PDFInfo
- Publication number
- US20180098699A1 US20180098699A1 US15/836,085 US201715836085A US2018098699A1 US 20180098699 A1 US20180098699 A1 US 20180098699A1 US 201715836085 A US201715836085 A US 201715836085A US 2018098699 A1 US2018098699 A1 US 2018098699A1
- Authority
- US
- United States
- Prior art keywords
- sensor
- inductor
- indicator
- radiation
- load
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0031—Implanted circuitry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/07—Endoradiosondes
- A61B5/076—Permanent implantations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/1459—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters invasive, e.g. introduced into the body by a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0242—Operational features adapted to measure environmental factors, e.g. temperature, pollution
- A61B2560/0247—Operational features adapted to measure environmental factors, e.g. temperature, pollution for compensation or correction of the measured physiological value
- A61B2560/0252—Operational features adapted to measure environmental factors, e.g. temperature, pollution for compensation or correction of the measured physiological value using ambient temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/08—Sensors provided with means for identification, e.g. barcodes or memory chips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
Definitions
- This invention relates to a circuit and method for processing the output of an implanted sensing device for detecting the presence or concentration of an analyte in a liquid or gaseous medium, such as, for example, the human body. More particularly, the invention relates to a circuit and method for processing the output of an implanted fluorescence sensor which indicates analyte concentration as a function of the fluorescent intensity of a fluorescent indicator.
- the implanted fluorescence sensor is a passive device, and contains no power source.
- the processing circuit powers the sensor through inductively coupled RF energy emitted by the processing circuit.
- the processing circuit receives information from the implanted sensor as variations in the load on the processing circuit.
- U.S. Pat. No. 5,517,313 the disclosure of which is incorporated herein by reference, describes a fluorescence sensing device comprising a layered array of a fluorescent indicator molecule-containing matrix (hereafter “fluorescent matrix”), a high-pass filter and a photodetector.
- fluorescent matrix a fluorescent indicator molecule-containing matrix
- a high-pass filter a light source, preferably a light-emitting diode (“LED”), is located at least partially within the indicator material, such that incident light from the light source causes the indicator molecules to fluoresce.
- the high-pass filter allows emitted light to reach the photodetector, while filtering out scattered incident light from the light source.
- An analyte is allowed to permeate the fluorescent matrix, changing the fluorescent properties of the indicator material in proportion to the amount of analyte present.
- the fluorescent emission is then detected and measured by the photodetector, thus providing a measure of the amount or concentration of analyte present within the environment of interest.
- One advantageous application of a sensor device of the type disclosed in the '313 patent is to implant the device in the body, either subcutaneously or intravenously or otherwise, to allow instantaneous measurements of analytes to be taken at any desired time. For example, it is desirable to measure the concentration of oxygen in the blood of patients under anesthesia, or of glucose in the blood of diabetic patients.
- an apparatus for retrieving information from a sensor device, comprising an internal sensor unit for taking quantitative analyte measurements, including a first coil forming part of a power supply for said sensor unit, a load coupled to said first coil, and a sensor circuit for modifying said load in accordance with sensor measurement information obtained by said sensor circuit; an external unit including a second coil which is mutually inductively coupled to said first coil upon said second coil coming into a predetermined proximity distance from said first coil, an oscillator for driving said second coil to induce a charging current in said first coil, and a detector for detecting variations in a load on said second coil induced by changes to said load in said internal sensor unit and for providing information signals corresponding to said load changes; and a processor for receiving and processing said information signals.
- FIG. 1 is a block diagram of one preferred embodiment according to the present invention.
- FIG. 2 is a schematic diagram of an internal sensor device unit according to one preferred embodiment of the invention.
- FIGS. 3 and 4 are waveform diagrams illustrating signal waveforms at various points in the sensor device circuit
- FIGS. 5A-5E are diagrams of signals produced by the external data receiving unit
- FIG. 6 is a schematic, section view of an implantable fluorescence-based sensor according to the invention.
- FIG. 7 is a schematic diagram of the fluorescence-based sensor shown in FIG. 6 illustrating the wave guide properties of the sensor
- FIG. 8 is a detailed view of the circled portion of FIG. 6 demonstrating internal reflection within the body of the sensor and a preferred construction of the sensor/tissue interface layer;
- FIG. 9 is a schematic diagram of an internal sensor device unit according to a second preferred embodiment of the invention.
- FIG. 10 is a timing diagram illustrating voltage levels of various terminals of the comparator of FIG. 9 as the detector circuit cycles through its operation.
- FIG. 1 shows a block diagram of one preferred embodiment of an implanted fluorescence sensor processing system according to the present invention.
- the system includes an external unit 101 and an internal unit 102 .
- the internal unit 102 would be implanted either subcutaneously or otherwise within the body of a subject.
- the internal unit contains optoelectronics circuitry 102 b , a component of which may be comprised of a fluorescence sensing device as described more fully hereinafter with reference to FIGS. 6-8 .
- the optoelectronics circuitry 102 b obtains quantitative measurement information and modifies a load 102 c as a function of the obtained information.
- the load 102 c in turn varies the amount of current through coil 102 d , which is coupled to coil 101 f of the external unit.
- An amplitude modulation (AM) demodulator 101 b detects the current variations induced in coil 101 f by coil 102 d coupled thereto, and applies the detected signal to processing circuitry, such as a pulse counter 101 c and computer interface 101 d , for processing the signal into computer-readable format for inputting to a computer 101 e.
- processing circuitry such as a pulse counter 101 c and computer interface 101 d , for processing the signal into computer-readable format for inputting to a computer 101 e.
- a variable RF oscillator 101 a provides an RF signal to coil 101 f , which in turn provides electromagnetic energy to coil 102 d , when the coils 101 f and 102 d are within close enough proximity to each other to allow sufficient inductive coupling between the coils.
- the energy from the RF signal provides operating power for the internal unit 102 to obtain quantitative measurements, which are used to vary the load 102 c and in turn provide a load variation to the coil 101 f that is detected by the external unit and decoded into information.
- the load variations are coupled from the internal unit to the external unit through the mutual coupling between the coils 101 f and 102 d .
- the loading can be improved by tuning both the internal coil and the external coil to approximately the same frequency, and increasing the Q factor of the resonant circuits by appropriate construction techniques. Because of their mutual coupling, a current change in one coil induces a current in the other coil. The induced current is detected and decoded into corresponding information.
- RF oscillator 101 a drives coil 101 f , which induces a current in coil 102 d .
- the induced current is rectified by a rectifier circuit 102 a and used to power the optoelectronics 102 b .
- Data is generated by the optoelectronics in the form of a pulse train having a frequency varying as a function of the intensity of light emitted by a fluorescence sensor, such as described in the aforementioned '313 patent.
- the pulse train modulates the load 102 c in a manner so as to temporarily short the rectifier output terminal to ground.
- This change in load causes a corresponding change in the current through the internal coil 102 d , thereby causing a change in the magnetic field surrounding external coil 101 f .
- This change in magnetic field causes a proportional change in the voltage across coil 101 f , which is observable as an amplitude modulation.
- the following equation describes the voltage seen on the external coil:
- V I[Z +(( ⁇ M ) 2 )/ Zs] (1)
- Equation (1) there is a direct relationship between the voltage across the external coil and the impedance presented by the internal sensor circuit. While the impedance Zs is a complex number having both a real and imaginary part, which corresponds respectively to changes in amplitude and frequency of the oscillation signal, the system according to the present embodiment deals only with the real part of the interaction. It will be recognized by those skilled in the art that both types of interaction may be detected by appropriately modifying the external circuit, to improve the signal-to-noise ratio.
- FIG. 2 shows a schematic diagram of one embodiment of an internal sensor device unit according to the invention.
- the coil 102 d (L 1 ) in conjunction with capacitor C 1 , diode D 1 (rectifier 102 a ) zener diode D 2 and capacitor C 2 constitute a power supply for the internal unit 102 .
- Current induced in coil L 1 by the RF voltage applied to external coil 101 f by oscillator 101 a (see FIG. 1 ) is resonated in the L-C tank formed by L 1 and capacitor C 1 , rectified by diode D 1 , and filtered by capacitor C 2 .
- Zener diode D 2 is provided to prevent the voltage being applied to the circuit from exceeding a maximum value, such as 5 volts.
- diode D 2 will start to conduct in its reverse breakdown region, preventing the capacitor C 2 from becoming overcharged with respect to the maximum allowable voltage for the circuit.
- Voltage regulator 205 receives the voltage from capacitor C 2 and produces a fixed output voltage V ref to the noninverting input of operational amplifier 201 .
- the output terminal of the operational amplifier 201 is connected to a light-emitting diode (LED) 202 connected in series with a feedback resistor R 1 .
- the inverting input terminal of operational amplifier 201 is supplied with the voltage across R 1 , to thereby regulate the current through LED 202 to V ref /R 1 (ignoring small bias current).
- Light emitted from LED 202 is incident on the sensor device (not shown) and causes the sensor device to emit light as a function of the amount of the particular analyte being monitored.
- Photoresistor 203 is connected in series with a capacitor C 3 , and the junction of the photoresistor and the capacitor C 3 is connected to the inverting input terminal of comparator 204 .
- the other end of photoresistor 203 is connected to the output terminal of the comparator 204 through a conductor V comp .
- the output of the comparator 204 is also connected to a load capacitor C 4 and a resistor network R 2 , R 3 and R 4 .
- the comparator forms a variable resistance oscillator, with switching points determined by the values of R 2 , R 3 and R 4 .
- C 3 is a charge-up capacitor, which determines the base frequency of the oscillator for a given light level. This frequency is given by
- Equation (3) can be inverted to determine the intensity of light for a given photoresistance; in conjunction with equation (2), the light intensity can be determined from frequency.
- the values given above are provided as examples only for purposes of explanation. Such values are determined on the basis of the particular photoresistor geometry and materials used.
- Capacitor C 3 begins to charge with time constant Rphoto*Ctime.
- C 3 will discharge through Rphoto. Therefore a 50% duty cycle is established, with the frequency being determined by equation (2).
- Rphoto varies as a function of incident light, given by equation (3).
- C 4 is a load capacitor, which causes a voltage across C 2 to decrease when the comparator switches states.
- C 4 must be charged from 0V to Vdc when comparator 204 switches to a high output level state.
- the current through C 4 is supplied by C 2 , causing the voltage across C 2 to decrease. This in turn causes current to flow through rectifier 102 a to begin charging capacitor C 2 , changing the instantaneous load on the tank circuit including internal coil 102 d .
- This load is reflected into the impedance of the external coil 101 f as given by equation (1).
- Channel 4 is the DC voltage on C 2
- channel 3 shows the same pulse on the external coil 101 f
- the output of the AM demodulator is shown at channel 2 .
- Channel 1 shows the output of a comparator which converts the AM demodulator output to a square wave capable of being processed by a digital counter.
- FIG. 4 shows two complete operation cycles, with the same channel designations indicating the same points in the circuit.
- FIGS. 5A-5E illustrate timing diagrams for a measurement reading.
- FIG. 5A shows the envelope of the RF voltage signal applied to the external coil;
- FIG. 5B shows the waveform of the internal power supply voltage;
- FIG. 5C shows a waveform of the intensity of LED 202 ;
- FIG. 5D shows the output of the AM demodulator 101 b ;
- FIG. 5E shows the timing of the state of circuit operations in accordance with the power supplied to the sensor unit.
- the internal unit power supply ramps up as the field strength increases.
- the AM demodulator output contains the measurement data and digital data in the form of ID codes and other parameters specific to the subject in which the internal unit is implanted. This data is encoded on the RF voltage signal through time division multiplexing of the optoelectronic output with digital identification and parameter storage circuits (not shown). The digital circuits use the RF voltage to generate appropriate clock signals.
- the internal storage circuits can store ID codes and parametric values such as calibration constants. This information is returned along with each reading or quantitative measurement.
- the signals are clocked out by switching from analog pulse train loading to digitally controlled loading at a predefined point in the measurement sequence. This point is detected in the external unit by detecting a predefined bit synchronization pattern in the output data stream.
- the ID number is used to identify a particular subject and to prevent data corruption when two or more subjects are in the vicinity of the external unit.
- the calibration factors are applied to the measurement information to obtain analyte levels in clinical units.
- the sensor 10 is composed of a sensor body 12 ; a matrix layer 14 coated over the exterior surface of the sensor body 12 , with fluorescent indicator molecules 16 distributed throughout the layer; a radiation source 18 , e.g. an LED, that emits radiation, including radiation over a wavelength or range of wavelengths which interact with the indicator molecules, i.e., in the case of a fluorescence-based sensor, a wavelength or range of wavelengths which cause the indicator molecules 16 to fluoresce; and a photosensitive element 20 , e.g.
- the sensor 10 further includes a module or housing 66 containing electronic circuitry, and a temperature sensor 64 for providing a temperature reading.
- indicator molecules 16 could simply be coated on the surface of the sensor body.
- the indicator molecules are contained within the matrix layer 14 , which comprises a biocompatible polymer matrix that is prepared according to methods known in the art and coated on the surface of the sensor body. Suitable biocompatible matrix materials, which must be permeable to the analyte, include methacrylates and hydrogels which advantageously can be made selectively permeable to the analyte.
- the sensor body 12 advantageously is formed from a suitable, optically transmissive polymer material which has a refractive index sufficiently different from that of the medium in which the sensor will be used such that the polymer will act as an optical wave guide.
- Preferred materials are acrylic polymers such as polymethylmethacrylate, polyhydroxypropylmethacrylate and the like, and polycarbonates such as those sold under the trademark Lexan®.
- the material allows radiation generated by the radiation source 18 (e.g., light at an appropriate wavelength in embodiments in which the radiation source is an LED) and, in the case of a fluorescence-based embodiment, fluorescent light emitted by the indicator molecules, to travel through it.
- Radiation source or LED 18 corresponds to LED 202 shown in FIG. 2 .
- radiation e.g., light
- the radiation source 18 is emitted by the radiation source 18 and at least some of this radiation is reflected internally at the surface of the sensor body 12 , e.g., as at location 22 , thereby “bouncing” back-and-forth throughout the interior of the sensor body 12 .
- the fluorescent indicator molecules 16 enters the sensor body 12 , either directly or after being reflected by the outermost surface (with respect to the sensor body 12 ) of the matrix layer 14 , as illustrated in region 30 .
- Such fluorescent light 28 is then reflected internally throughout the sensor body 12 , much like the radiation emitted by the radiation source 18 is, and, like the radiation emitted by the radiation source, some will strike the interface between the sensor body and the surrounding medium at angles too small to be reflected and will pass back out of the sensor body.
- the senor 10 may also include reflective coatings 32 formed on the ends of the sensor body 12 , between the exterior surface of the sensor body and the matrix layer 14 , to maximize or enhance the internal reflection of the radiation and/or light emitted by fluorescent indicator molecules.
- the reflective coatings may be formed, for example, from paint or from a metallized material.
- An optical filter 34 preferably is provided on the light-sensitive surface of the photodetector 20 , which is manufactured of a photosensitive material.
- Photodetector 20 corresponds to photodetector 203 shown in FIG. 2 .
- Filter 34 prevents or substantially reduces the amount of radiation generated by the source 18 from impinging on the photosensitive surface of the photosensitive element 20 .
- the filter allows fluorescent light emitted by fluorescent indicator molecules to pass through it to strike the photosensitive region of the detector. This significantly reduces “noise” in the photodetector signal that is attributable to incident radiation from the source 18 .
- the specific composition of the matrix layer 14 and the indicator molecules 16 may vary depending on the particular analyte the sensor is to be used to detect and/or where the sensor is to be used to detect the analyte (i.e., in the blood or in subcutaneous tissues).
- the matrix layer 14 facilitate exposure of the indicator molecules to the analyte and that the optical characteristics of the indicator molecules (e.g., the level of fluorescence of fluorescent indicator molecules) are a function of the concentration of the specific analyte to which the indicator molecules are exposed.
- the senor 10 is formed, preferably, in a smooth, oblong or rounded shape.
- it has the approximate size and shape of a bean or a pharmaceutical gelatin capsule, i.e., it is on the order of approximately 300-500 microns to approximately 0.5 inch in length L and on the order of approximately 300 microns to approximately 0.3 inch in depth D, with generally smooth, rounded surfaces throughout.
- the device of course could be larger or smaller depending on the materials used and upon the intended uses of the device.
- This configuration permits the sensor 10 to be implanted into the human body, i.e., dermally or into underlying tissues (including into organs or blood vessels) without the sensor interfering with essential bodily functions or causing excessive pain or discomfort.
- the “foreign body response” is most often fibrotic encapsulation, i.e., the formation of scar tissue.
- Glucose a primary analyte which sensors according to the invention are expected to be used to detect—may have its rate of diffusion or transport hindered by such fibrotic encapsulation.
- molecular oxygen (O2) which is very small, may have its rate of diffusion or transport hindered by such fibrotic encapsulation as well. This is simply because the cells forming the fibrotic encapsulation (scar tissue) can be quite dense in nature or have metabolic characteristics different from that of normal tissue.
- a sensor/tissue interface layer overlying the surface of the sensor body 12 and/or the indicator molecules themselves when the indicator molecules are immobilized directly on the surface of the sensor body, or overlying the surface of the matrix layer 14 when the indicator molecules are contained therein—is prepared from a material which causes little or acceptable levels of fibrotic encapsulation to form.
- Two examples of such materials described in the literature as having this characteristic are PrecludeTM Periocardial Membrane, available from W.L. Gore, and polyisobutylene covalently combined with hydrophiles as described in Kennedy, “Tailoring Polymers for Biological Uses,” Chemtech, February 1994, pp. 24-31.
- the sensor/tissue interface layer 36 may include three sublayers 36 a , 36 b , and 36 c .
- the sublayer 36 a a layer which promotes tissue ingrowth, preferably is made from a biocompatible material that permits the penetration of capillaries 37 into it, even as fibrotic cells 39 (scar tissue) accumulate on it.
- Gore-Tex® Vascular Graft material ePTFE
- Dacron® PET
- MEDPOR Biomaterial produced from high-density polyethylene available from POREX Surgical Inc.
- materials whose basic composition, pore size, and pore architecture promote tissue and vascular ingrowth into the tissue ingrowth layer.
- the sublayer 36 b preferably is a biocompatible layer with a pore size (less than 5 micrometers) that is significantly smaller than the pore size of the tissue ingrowth sublayer 36 a so as to prevent tissue ingrowth.
- a presently preferred material from which the sublayer 36 b is to be made is the Preclude Periocardial Membrane (formerly called GORE-TEX Surgical Membrane), available from W.L. Gore, Inc., which consists of expanded polytetra-fluoroethylene (ePTFE).
- the third sublayer 36 c acts as a molecular sieve, i.e., it provides a molecular weight cut-off function, excluding molecules such as immunoglobulins, proteins, and glycoproteins while allowing the analyte or analytes of interest to pass through it to the indicator molecules (either coated directly on the sensor body 12 or immobilized within a matrix layer 14 ).
- Many well known cellulose-type membranes e.g., of the sort used in kidney dialysis filtration cartridges, may be used for the molecular weight cut-off layer 36 c.
- the senor as shown in FIG. 6 is wholly self-contained such that no electrical leads extend into or out of the sensor body, either to supply power to the sensor (e.g., for driving the source 18 ) or to transmit signals from the sensor. All of the electronics illustrated in FIG. 2 may be housed in a module 66 as shown in FIG. 6 .
- FIG. 9 A second preferred embodiment of the invention is shown in FIG. 9 , in which two detectors are employed, a signal channel detector 901 and a reference channel detector 902 .
- a single detector 203 is used to detect radiation from the fluorescent indicator sensor device. While this system works well, it is possible that various disturbances to the system will occur that may affect the accuracy of the sensor output as originally calibrated.
- Such disturbances include: changes or drift in the component operation intrinsic to the sensor make-up; environmental conditions external to the sensor; or combinations thereof.
- Internal variables may be introduced by, among other things: aging of the sensor's radiation source; changes affecting the performance or sensitivity of the photosensitive element; deterioration of the indicator molecules; changes in the radiation transmissivity of the sensor body, of the indicator matrix layer, etc.; and changes in other sensor components; etc.
- the optical reference channel could also be used to compensate or correct for environmental factors (e.g., factors external to the sensor) which could affect the optical characteristics or apparent optical characteristics of the indicator molecule irrespective of the presence or concentration of the analyte.
- exemplary external factors could include, among other things: the temperature level; the pH level; the ambient light present; the reflectivity or the turbidity of the medium that the sensor is applied in; etc.
- the optical reference channel can be used to compensate for such variations in the operating conditions of the sensor.
- the reference channel is identical to the signal channel in all respects except that the reference channel is not responsive to the analyte being measured.
- reference channels Use of reference channels in optical measurement is generally known in the art.
- U.S. Pat. No. 3,612,866 the entire disclosure of which is incorporated herein by reference, describes a fluorescent oxygen sensor having a reference channel containing the same indicator chemistry as the measuring channel, except that the reference channel is coated with varnish to render it impermeable to oxygen.
- the emission spectra which is less sensitive to oxygen is used as a reference to ratio the two emission intensities.
- the signal and reference channel detectors are back-to-back photodiodes 901 and 902 . While photodiodes are shown, many other types of photodetectors also could be used, such as photoresistors, phototransistors, and the like.
- LED 903 corresponds to light source 202 in FIG. 2 .
- comparator 904 is set to trigger at 1 ⁇ 3 and 2 ⁇ 3 of the supply voltage Vss, as biased by resistors 905 , 906 , and 907 .
- the trigger voltages for comparator 904 could be modified, if desired, by changing the values of the resistors.
- Capacitor C 2 is a timing element, the value of which is adjusted for the magnitude of the signal and reference channels.
- the incident light power impinging upon the photodiode detectors changes with analyte concentration.
- FIG. 10 is a timing diagram showing the voltage levels of the terminals 904 a , 904 b , and 904 c of the comparator 904 .
- the voltage level of output terminal 904 c is at ground (low output state)
- the voltage level of capacitor C 2 (which corresponds to the voltage level at input terminal 904 b ) is at 2 ⁇ 3 Vss
- the voltage level of input terminal 904 a is at 1 ⁇ 3 Vss.
- photodiode 901 is forward-biased and photodiode 902 is reverse-biased.
- the voltage drop across the forward-biased photodiode 901 is simply its threshold voltage, while the reverse-biased photodiode 902 exhibits a current flow proportional to the incident light impinging upon it.
- P (dV*C 2 )/(dt*R), where
- dt time to charge or discharge (as measured by the external unit)
- the comparator 904 switches to a high output state Vss on output terminal 904 c .
- the trigger point (input terminal 904 a ) is now at 2 ⁇ 3 Vss, and the polarity of the photodiodes 901 and 902 is now reversed. That is, photodiode 901 is now reverse-biased and photodiode 902 is now forward-biased.
- the comparator output will be a 50% duty cycle. If the incident light intensity on each photodiode detector 901 and 902 is equal, then the comparator output will be a 50% duty cycle. If the incident light on each photodiode detector is not equal, then the capacitor charge current will be different than the capacitor discharge current. This is the case shown in FIG. 10 , wherein the capacitor charge current is higher than the capacitor discharge current. Because the same capacitor is charged and discharged, the different charge and discharge times are a function only of the difference between the incident light levels on the two photodiode detectors. Consequently, the duty cycle of the squarewave produced by the comparator 904 is indicative of changes between incident light on the signal channel photodiode and incident light on the reference channel photodiode. Suitable algorithms for taking into account changes in duty cycle of the squarewave from the comparator in determining analyte concentration are generally known in the art (see prior art references discussed supra) and will not be further discussed herein.
- resistor 910 which is connected to the output terminal 904 c of the comparator 904 .
- Vss/R 910 is drawn from the voltage regulator 909 .
- resistor 910 acts as a load that is switched into and out of the circuit at a rate determined by the concentration of analyte and the output of the reference channel.
- the switching of the resistor load also switches the load on the tank including internal coil 908 .
- the change in impedance of the tank caused by the changing load is detected by a corresponding change in load on the inductively coupled external coil, as described above.
- the voltage regulator 909 removes any effects caused by coil placement in the field.
- the LED 903 emits the excitation light for the indicator molecule sensor. Power for the LED 903 is provided by the voltage regulator. It is important to keep the intensity of the LED constant during an analyte measurement reading. Once the output of the voltage regulator is in regulation, the LED intensity will be constant. The step recovery time of the regulator is very fast, with the transition between loading states being rapid enough to permit differentiation and AC coupling in the external unit.
- fluorescence-based sensor embodiments described in FIGS. 6-8 are just examples to which the disclosed invention may be applied.
- the present invention may also be applied in a number of other applications such as, for example, an absorbance-based sensor or a refractive-index-based sensor as described in U.S. patent application Ser. No. 09/383,148, filed Aug. 28, 1999, incorporated herein by reference.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Optics & Photonics (AREA)
- Computer Networks & Wireless Communication (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
Description
- This application is a continuation of U.S. patent application Ser. No. 15/456,980, which was filed on Mar. 13, 2017, which is a continuation of U.S. patent application Ser. No. 12/493,478, which was filed on Jun. 29, 2009, abandoned, and is a divisional of U.S. patent application Ser. No. 10/332,619, which was filed on Oct. 21, 2003, now U.S. Pat. No. 7,553,280, and is a national stage application filed under 35 U.S.C. § 371 of PCT/US01/20390, which was filed on Jun. 27, 2001, and is a continuation-in-part of U.S. patent application Ser. No. 09/605,706, which was filed on Jun. 29, 2000, now U.S. Pat. No. 6,400,974, all of which are incorporated by reference herein in their entireties.
- This invention relates to a circuit and method for processing the output of an implanted sensing device for detecting the presence or concentration of an analyte in a liquid or gaseous medium, such as, for example, the human body. More particularly, the invention relates to a circuit and method for processing the output of an implanted fluorescence sensor which indicates analyte concentration as a function of the fluorescent intensity of a fluorescent indicator. The implanted fluorescence sensor is a passive device, and contains no power source. The processing circuit powers the sensor through inductively coupled RF energy emitted by the processing circuit. The processing circuit receives information from the implanted sensor as variations in the load on the processing circuit.
- U.S. Pat. No. 5,517,313, the disclosure of which is incorporated herein by reference, describes a fluorescence sensing device comprising a layered array of a fluorescent indicator molecule-containing matrix (hereafter “fluorescent matrix”), a high-pass filter and a photodetector. In this device, a light source, preferably a light-emitting diode (“LED”), is located at least partially within the indicator material, such that incident light from the light source causes the indicator molecules to fluoresce. The high-pass filter allows emitted light to reach the photodetector, while filtering out scattered incident light from the light source. An analyte is allowed to permeate the fluorescent matrix, changing the fluorescent properties of the indicator material in proportion to the amount of analyte present. The fluorescent emission is then detected and measured by the photodetector, thus providing a measure of the amount or concentration of analyte present within the environment of interest.
- One advantageous application of a sensor device of the type disclosed in the '313 patent is to implant the device in the body, either subcutaneously or intravenously or otherwise, to allow instantaneous measurements of analytes to be taken at any desired time. For example, it is desirable to measure the concentration of oxygen in the blood of patients under anesthesia, or of glucose in the blood of diabetic patients.
- In order for the measurement information obtained to be used, it has to be retrieved from the sensing device. Because of the size and accessibility constraints on a sensor device implanted in the body, there are shortcomings associated with providing the sensing device with data transmission circuitry and/or a power supply. Therefore, there is a need in the art for an improved sensor device implanted in the body and system for retrieving data from the implanted sensor device.
- In accordance with the present invention, an apparatus is provided for retrieving information from a sensor device, comprising an internal sensor unit for taking quantitative analyte measurements, including a first coil forming part of a power supply for said sensor unit, a load coupled to said first coil, and a sensor circuit for modifying said load in accordance with sensor measurement information obtained by said sensor circuit; an external unit including a second coil which is mutually inductively coupled to said first coil upon said second coil coming into a predetermined proximity distance from said first coil, an oscillator for driving said second coil to induce a charging current in said first coil, and a detector for detecting variations in a load on said second coil induced by changes to said load in said internal sensor unit and for providing information signals corresponding to said load changes; and a processor for receiving and processing said information signals.
- The invention will be more fully understood with reference to the following detailed description of a preferred embodiment in conjunction with the accompanying drawings, which are given by way of illustration only and thus are not limitative of the present invention, and wherein:
-
FIG. 1 is a block diagram of one preferred embodiment according to the present invention; -
FIG. 2 is a schematic diagram of an internal sensor device unit according to one preferred embodiment of the invention; -
FIGS. 3 and 4 are waveform diagrams illustrating signal waveforms at various points in the sensor device circuit; -
FIGS. 5A-5E are diagrams of signals produced by the external data receiving unit; -
FIG. 6 is a schematic, section view of an implantable fluorescence-based sensor according to the invention; -
FIG. 7 is a schematic diagram of the fluorescence-based sensor shown inFIG. 6 illustrating the wave guide properties of the sensor; -
FIG. 8 is a detailed view of the circled portion ofFIG. 6 demonstrating internal reflection within the body of the sensor and a preferred construction of the sensor/tissue interface layer; -
FIG. 9 is a schematic diagram of an internal sensor device unit according to a second preferred embodiment of the invention; and -
FIG. 10 is a timing diagram illustrating voltage levels of various terminals of the comparator ofFIG. 9 as the detector circuit cycles through its operation. -
FIG. 1 shows a block diagram of one preferred embodiment of an implanted fluorescence sensor processing system according to the present invention. - The system includes an
external unit 101 and aninternal unit 102. In one example of an application of the system, theinternal unit 102 would be implanted either subcutaneously or otherwise within the body of a subject. The internal unit containsoptoelectronics circuitry 102 b, a component of which may be comprised of a fluorescence sensing device as described more fully hereinafter with reference toFIGS. 6-8 . Theoptoelectronics circuitry 102 b obtains quantitative measurement information and modifies aload 102 c as a function of the obtained information. Theload 102 c in turn varies the amount of current throughcoil 102 d, which is coupled to coil 101 f of the external unit. An amplitude modulation (AM)demodulator 101 b detects the current variations induced incoil 101 f bycoil 102 d coupled thereto, and applies the detected signal to processing circuitry, such as apulse counter 101 c andcomputer interface 101 d, for processing the signal into computer-readable format for inputting to acomputer 101 e. - A
variable RF oscillator 101 a provides an RF signal to coil 101 f, which in turn provides electromagnetic energy to coil 102 d, when thecoils internal unit 102 to obtain quantitative measurements, which are used to vary theload 102 c and in turn provide a load variation to thecoil 101 f that is detected by the external unit and decoded into information. The load variations are coupled from the internal unit to the external unit through the mutual coupling between thecoils -
RF oscillator 101 adrives coil 101 f, which induces a current incoil 102 d. The induced current is rectified by arectifier circuit 102 a and used to power theoptoelectronics 102 b. Data is generated by the optoelectronics in the form of a pulse train having a frequency varying as a function of the intensity of light emitted by a fluorescence sensor, such as described in the aforementioned '313 patent. The pulse train modulates theload 102 c in a manner so as to temporarily short the rectifier output terminal to ground. This change in load causes a corresponding change in the current through theinternal coil 102 d, thereby causing a change in the magnetic field surroundingexternal coil 101 f. This change in magnetic field causes a proportional change in the voltage acrosscoil 101 f, which is observable as an amplitude modulation. The following equation describes the voltage seen on the external coil: -
V=I[Z+((ωM)2)/Zs] (1) - where
-
- V=voltage across the external coil
- I=current in the external coil
- Z=impedance of the primary coil
- ω=frequency (rad/sec)
- M=mutual inductance between the coils
- Zs=impedance of the sensor equivalent circuit
- As shown by equation (1), there is a direct relationship between the voltage across the external coil and the impedance presented by the internal sensor circuit. While the impedance Zs is a complex number having both a real and imaginary part, which corresponds respectively to changes in amplitude and frequency of the oscillation signal, the system according to the present embodiment deals only with the real part of the interaction. It will be recognized by those skilled in the art that both types of interaction may be detected by appropriately modifying the external circuit, to improve the signal-to-noise ratio.
-
FIG. 2 shows a schematic diagram of one embodiment of an internal sensor device unit according to the invention. Thecoil 102 d (L1) in conjunction with capacitor C1, diode D1 (rectifier 102 a) zener diode D2 and capacitor C2 constitute a power supply for theinternal unit 102. Current induced in coil L1 by the RF voltage applied toexternal coil 101 f byoscillator 101 a (seeFIG. 1 ) is resonated in the L-C tank formed by L1 and capacitor C1, rectified by diode D1, and filtered by capacitor C2. Zener diode D2 is provided to prevent the voltage being applied to the circuit from exceeding a maximum value, such as 5 volts. As is known by those skilled in the art, if the voltage across capacitor C2 starts to exceed the reverse breakdown voltage of the zener diode D2, diode D2 will start to conduct in its reverse breakdown region, preventing the capacitor C2 from becoming overcharged with respect to the maximum allowable voltage for the circuit. -
Voltage regulator 205 receives the voltage from capacitor C2 and produces a fixed output voltage Vref to the noninverting input ofoperational amplifier 201. The output terminal of theoperational amplifier 201 is connected to a light-emitting diode (LED) 202 connected in series with a feedback resistor R1. The inverting input terminal ofoperational amplifier 201 is supplied with the voltage across R1, to thereby regulate the current throughLED 202 to Vref/R1 (ignoring small bias current). Light emitted fromLED 202 is incident on the sensor device (not shown) and causes the sensor device to emit light as a function of the amount of the particular analyte being monitored. The light from the sensor device impinges on thephotosensitive resistor 203, whose resistance changes as a function of the amount of light incident thereon.Photoresistor 203 is connected in series with a capacitor C3, and the junction of the photoresistor and the capacitor C3 is connected to the inverting input terminal ofcomparator 204. The other end ofphotoresistor 203 is connected to the output terminal of thecomparator 204 through a conductor Vcomp. The output of thecomparator 204 is also connected to a load capacitor C4 and a resistor network R2, R3 and R4. The comparator forms a variable resistance oscillator, with switching points determined by the values of R2, R3 and R4. C3 is a charge-up capacitor, which determines the base frequency of the oscillator for a given light level. This frequency is given by -
f=1/(1.38*Rphoto*C3) (2) -
Rphoto=R 2fc[10−γ log(a/2fc)] (3) - Where
-
- R2fc (=24 kΩ) is the resistance of
photoresistor 203 at 2 footcandles - γ(=0.8) is the sensitivity of the photoresistor
- a=the incident light level in footcandles
- R2fc (=24 kΩ) is the resistance of
- Equation (3) can be inverted to determine the intensity of light for a given photoresistance; in conjunction with equation (2), the light intensity can be determined from frequency. Of course, the values given above are provided as examples only for purposes of explanation. Such values are determined on the basis of the particular photoresistor geometry and materials used.
- The
comparator 204 switches to a high output when Vtime=V/3, Vcomp=V, and Vtrip=2V/3. Capacitor C3 begins to charge with time constant Rphoto*Ctime. When Vtime reaches 2V/3 the comparator switches states to a low output, changing Vcomp to Vcomp=0, and Vtrip to Vtrip=V/3. At this point C3 will discharge through Rphoto. Therefore a 50% duty cycle is established, with the frequency being determined by equation (2). Rphoto varies as a function of incident light, given by equation (3). - C4 is a load capacitor, which causes a voltage across C2 to decrease when the comparator switches states. C4 must be charged from 0V to Vdc when
comparator 204 switches to a high output level state. The current through C4 is supplied by C2, causing the voltage across C2 to decrease. This in turn causes current to flow throughrectifier 102 a to begin charging capacitor C2, changing the instantaneous load on the tank circuit includinginternal coil 102 d. This load is reflected into the impedance of theexternal coil 101 f as given by equation (1). - The sensor operation for a single pulse is illustrated in
FIG. 3 .Channel 4 is the DC voltage on C2,channel 3 shows the same pulse on theexternal coil 101 f, and the output of the AM demodulator is shown atchannel 2.Channel 1 shows the output of a comparator which converts the AM demodulator output to a square wave capable of being processed by a digital counter.FIG. 4 shows two complete operation cycles, with the same channel designations indicating the same points in the circuit. - The
external unit 101 uses a microprocessor to implement thepulse counter 101 c. When sufficient data has been received to obtain a valid reading, the processor shuts down the RF oscillator.FIGS. 5A-5E illustrate timing diagrams for a measurement reading.FIG. 5A shows the envelope of the RF voltage signal applied to the external coil;FIG. 5B shows the waveform of the internal power supply voltage;FIG. 5C shows a waveform of the intensity ofLED 202;FIG. 5D shows the output of theAM demodulator 101 b; andFIG. 5E shows the timing of the state of circuit operations in accordance with the power supplied to the sensor unit. The internal unit power supply ramps up as the field strength increases. When the power supply output crosses the threshold voltage of the LED plus the feedback voltage, the LED turns on. The AM demodulator output contains the measurement data and digital data in the form of ID codes and other parameters specific to the subject in which the internal unit is implanted. This data is encoded on the RF voltage signal through time division multiplexing of the optoelectronic output with digital identification and parameter storage circuits (not shown). The digital circuits use the RF voltage to generate appropriate clock signals. - The internal storage circuits can store ID codes and parametric values such as calibration constants. This information is returned along with each reading or quantitative measurement. The signals are clocked out by switching from analog pulse train loading to digitally controlled loading at a predefined point in the measurement sequence. This point is detected in the external unit by detecting a predefined bit synchronization pattern in the output data stream. The ID number is used to identify a particular subject and to prevent data corruption when two or more subjects are in the vicinity of the external unit. The calibration factors are applied to the measurement information to obtain analyte levels in clinical units.
- A
sensor 10 according to one aspect of the invention, which operates based on the fluorescence of fluorescent indicator molecules, is shown inFIG. 6 . Thesensor 10 is composed of asensor body 12; amatrix layer 14 coated over the exterior surface of thesensor body 12, withfluorescent indicator molecules 16 distributed throughout the layer; aradiation source 18, e.g. an LED, that emits radiation, including radiation over a wavelength or range of wavelengths which interact with the indicator molecules, i.e., in the case of a fluorescence-based sensor, a wavelength or range of wavelengths which cause theindicator molecules 16 to fluoresce; and aphotosensitive element 20, e.g. a photodetector, which, in the case of a fluorescence-based sensor, is sensitive to fluorescent light emitted by theindicator molecules 16 such that a signal is generated in response thereto that is indicative of the level of fluorescence of the indicator molecules. Thesensor 10 further includes a module orhousing 66 containing electronic circuitry, and atemperature sensor 64 for providing a temperature reading. In the simplest embodiments,indicator molecules 16 could simply be coated on the surface of the sensor body. In preferred embodiments, however, the indicator molecules are contained within thematrix layer 14, which comprises a biocompatible polymer matrix that is prepared according to methods known in the art and coated on the surface of the sensor body. Suitable biocompatible matrix materials, which must be permeable to the analyte, include methacrylates and hydrogels which advantageously can be made selectively permeable to the analyte. - The
sensor body 12 advantageously is formed from a suitable, optically transmissive polymer material which has a refractive index sufficiently different from that of the medium in which the sensor will be used such that the polymer will act as an optical wave guide. Preferred materials are acrylic polymers such as polymethylmethacrylate, polyhydroxypropylmethacrylate and the like, and polycarbonates such as those sold under the trademark Lexan®. The material allows radiation generated by the radiation source 18 (e.g., light at an appropriate wavelength in embodiments in which the radiation source is an LED) and, in the case of a fluorescence-based embodiment, fluorescent light emitted by the indicator molecules, to travel through it. Radiation source orLED 18 corresponds toLED 202 shown inFIG. 2 . - As shown in
FIG. 7 , radiation (e.g., light) is emitted by theradiation source 18 and at least some of this radiation is reflected internally at the surface of thesensor body 12, e.g., as atlocation 22, thereby “bouncing” back-and-forth throughout the interior of thesensor body 12. - It has been found that light reflected from the interface of the sensor body and the surrounding medium is capable of interacting with indicator molecules coated on the surface (whether coated directly thereon or contained within a matrix), e.g., exciting fluorescence in fluorescent indicator molecules coated on the surface. In addition, light which strikes the interface at angles (measured relative to a direction normal to the interface) too small to be reflected passes through the interface and also excites fluorescence in fluorescent indicator molecules. Other modes of interaction between the light (or other radiation) and the interface and the indicator molecules have also been found to be useful depending on the construction of and application for the sensor. Such other modes include evanescent excitation and surface plasma resonance type excitation.
- As demonstrated by
FIG. 8 , at least some of the light emitted by thefluorescent indicator molecules 16 enters thesensor body 12, either directly or after being reflected by the outermost surface (with respect to the sensor body 12) of thematrix layer 14, as illustrated inregion 30. Suchfluorescent light 28 is then reflected internally throughout thesensor body 12, much like the radiation emitted by theradiation source 18 is, and, like the radiation emitted by the radiation source, some will strike the interface between the sensor body and the surrounding medium at angles too small to be reflected and will pass back out of the sensor body. - As further illustrated in
FIG. 6 , thesensor 10 may also includereflective coatings 32 formed on the ends of thesensor body 12, between the exterior surface of the sensor body and thematrix layer 14, to maximize or enhance the internal reflection of the radiation and/or light emitted by fluorescent indicator molecules. The reflective coatings may be formed, for example, from paint or from a metallized material. - An
optical filter 34 preferably is provided on the light-sensitive surface of thephotodetector 20, which is manufactured of a photosensitive material.Photodetector 20 corresponds to photodetector 203 shown inFIG. 2 .Filter 34, as is known from the prior art, prevents or substantially reduces the amount of radiation generated by thesource 18 from impinging on the photosensitive surface of thephotosensitive element 20. At the same time, the filter allows fluorescent light emitted by fluorescent indicator molecules to pass through it to strike the photosensitive region of the detector. This significantly reduces “noise” in the photodetector signal that is attributable to incident radiation from thesource 18. - The application for which the
sensor 10 according to one aspect of the invention was developed in particular—although by no means the only application for which it is suitable—is measuring various biological analytes in the human body, e.g., glucose, oxygen, toxins, pharmaceuticals or other drugs, hormones, and other metabolic analytes. The specific composition of thematrix layer 14 and theindicator molecules 16 may vary depending on the particular analyte the sensor is to be used to detect and/or where the sensor is to be used to detect the analyte (i.e., in the blood or in subcutaneous tissues). Two constant requirements, however, are that thematrix layer 14 facilitate exposure of the indicator molecules to the analyte and that the optical characteristics of the indicator molecules (e.g., the level of fluorescence of fluorescent indicator molecules) are a function of the concentration of the specific analyte to which the indicator molecules are exposed. - To facilitate use in-situ in the human body, the
sensor 10 is formed, preferably, in a smooth, oblong or rounded shape. Advantageously, it has the approximate size and shape of a bean or a pharmaceutical gelatin capsule, i.e., it is on the order of approximately 300-500 microns to approximately 0.5 inch in length L and on the order of approximately 300 microns to approximately 0.3 inch in depth D, with generally smooth, rounded surfaces throughout. The device of course could be larger or smaller depending on the materials used and upon the intended uses of the device. This configuration permits thesensor 10 to be implanted into the human body, i.e., dermally or into underlying tissues (including into organs or blood vessels) without the sensor interfering with essential bodily functions or causing excessive pain or discomfort. - Moreover, it will be appreciated that any implant placed within the human (or any other animal's) body—even an implant that is comprised of “biocompatible” materials—will cause, to some extent, a “foreign body response” within the organism into which the implant is inserted, simply by virtue of the fact that the implant presents a stimulus. In the case of a
sensor 10 that is implanted within the human body, the “foreign body response” is most often fibrotic encapsulation, i.e., the formation of scar tissue. Glucose—a primary analyte which sensors according to the invention are expected to be used to detect—may have its rate of diffusion or transport hindered by such fibrotic encapsulation. Even molecular oxygen (O2), which is very small, may have its rate of diffusion or transport hindered by such fibrotic encapsulation as well. This is simply because the cells forming the fibrotic encapsulation (scar tissue) can be quite dense in nature or have metabolic characteristics different from that of normal tissue. - To overcome this potential hindrance to or delay in exposing the indicator molecules to biological analytes, two primary approaches are contemplated. According to one approach, which is perhaps the simplest approach, a sensor/tissue interface layer—overlying the surface of the
sensor body 12 and/or the indicator molecules themselves when the indicator molecules are immobilized directly on the surface of the sensor body, or overlying the surface of thematrix layer 14 when the indicator molecules are contained therein—is prepared from a material which causes little or acceptable levels of fibrotic encapsulation to form. Two examples of such materials described in the literature as having this characteristic are Preclude™ Periocardial Membrane, available from W.L. Gore, and polyisobutylene covalently combined with hydrophiles as described in Kennedy, “Tailoring Polymers for Biological Uses,” Chemtech, February 1994, pp. 24-31. - Alternatively, a sensor/tissue interface layer that is composed of several layers of specialized biocompatible materials can be provided over the sensor. As shown in
FIG. 8 , for example, the sensor/tissue interface layer 36 may include threesublayers sublayer 36 a, a layer which promotes tissue ingrowth, preferably is made from a biocompatible material that permits the penetration ofcapillaries 37 into it, even as fibrotic cells 39 (scar tissue) accumulate on it. Gore-Tex® Vascular Graft material (ePTFE), Dacron® (PET) Vascular Graft materials which have been in use for many years, and MEDPOR Biomaterial produced from high-density polyethylene (available from POREX Surgical Inc.) are examples of materials whose basic composition, pore size, and pore architecture promote tissue and vascular ingrowth into the tissue ingrowth layer. - The
sublayer 36 b, on the other hand, preferably is a biocompatible layer with a pore size (less than 5 micrometers) that is significantly smaller than the pore size of thetissue ingrowth sublayer 36 a so as to prevent tissue ingrowth. A presently preferred material from which thesublayer 36 b is to be made is the Preclude Periocardial Membrane (formerly called GORE-TEX Surgical Membrane), available from W.L. Gore, Inc., which consists of expanded polytetra-fluoroethylene (ePTFE). - The
third sublayer 36 c acts as a molecular sieve, i.e., it provides a molecular weight cut-off function, excluding molecules such as immunoglobulins, proteins, and glycoproteins while allowing the analyte or analytes of interest to pass through it to the indicator molecules (either coated directly on thesensor body 12 or immobilized within a matrix layer 14). Many well known cellulose-type membranes, e.g., of the sort used in kidney dialysis filtration cartridges, may be used for the molecular weight cut-off layer 36 c. - As will be recognized, the sensor as shown in
FIG. 6 is wholly self-contained such that no electrical leads extend into or out of the sensor body, either to supply power to the sensor (e.g., for driving the source 18) or to transmit signals from the sensor. All of the electronics illustrated inFIG. 2 may be housed in amodule 66 as shown inFIG. 6 . - A second preferred embodiment of the invention is shown in
FIG. 9 , in which two detectors are employed, asignal channel detector 901 and areference channel detector 902. In the first embodiment as shown inFIG. 2 , asingle detector 203 is used to detect radiation from the fluorescent indicator sensor device. While this system works well, it is possible that various disturbances to the system will occur that may affect the accuracy of the sensor output as originally calibrated. - Examples of such disturbances include: changes or drift in the component operation intrinsic to the sensor make-up; environmental conditions external to the sensor; or combinations thereof. Internal variables may be introduced by, among other things: aging of the sensor's radiation source; changes affecting the performance or sensitivity of the photosensitive element; deterioration of the indicator molecules; changes in the radiation transmissivity of the sensor body, of the indicator matrix layer, etc.; and changes in other sensor components; etc. In other examples, the optical reference channel could also be used to compensate or correct for environmental factors (e.g., factors external to the sensor) which could affect the optical characteristics or apparent optical characteristics of the indicator molecule irrespective of the presence or concentration of the analyte. In this regard, exemplary external factors could include, among other things: the temperature level; the pH level; the ambient light present; the reflectivity or the turbidity of the medium that the sensor is applied in; etc. The optical reference channel can be used to compensate for such variations in the operating conditions of the sensor. The reference channel is identical to the signal channel in all respects except that the reference channel is not responsive to the analyte being measured.
- Use of reference channels in optical measurement is generally known in the art. For example, U.S. Pat. No. 3,612,866, the entire disclosure of which is incorporated herein by reference, describes a fluorescent oxygen sensor having a reference channel containing the same indicator chemistry as the measuring channel, except that the reference channel is coated with varnish to render it impermeable to oxygen.
- U.S. Pat. Nos. 4,861,727 and 5,190,729, the entire disclosures of which are incorporated herein by reference, describe oxygen sensors employing two different lanthanide-based indicator chemistries that emit at two different wavelengths, a terbium-based indicator being quenched by oxygen and a europium-based indicator being largely unaffected by oxygen. U.S. Pat. No. 5,094,959, the entire disclosure of which is also incorporated herein by reference, describes an oxygen sensor in which a single indicator molecule is irradiated at a certain wavelength and the fluorescence emitted by the molecule is measured over two different emission spectra having two different sensitivities to oxygen. Specifically, the emission spectra which is less sensitive to oxygen is used as a reference to ratio the two emission intensities. U.S. Pat. Nos. 5,462,880 and 5,728,422, the entire disclosures of which are also incorporated herein by reference, describe a ratiometric fluorescence oxygen sensing method employing a reference molecule that is substantially unaffected by oxygen and has a photodecomposition rate similar to the indicator molecule. Additionally, Muller, B., et al., ANALYST, Vol. 121, pp. 339-343 (March 1996), the entire disclosure of which is incorporated herein by reference, describes a fluorescence sensor for dissolved CO2, in which a blue LED light source is directed through a fiber optic coupler to an indicator channel and to a separate reference photodetector which detects changes in the LED light intensity.
- In addition, U.S. Pat. No. 4,580,059, the entire disclosure of which is incorporated herein by reference, describes a fluorescent-based sensor containing a reference light measuring cell for measuring changes in the intensity of the excitation light source—see, e.g.,
column 10,lines 1, et seq. - As shown in
FIG. 9 , the signal and reference channel detectors are back-to-back photodiodes LED 903 corresponds tolight source 202 inFIG. 2 . In operation,comparator 904 is set to trigger at ⅓ and ⅔ of the supply voltage Vss, as biased byresistors comparator 904 could be modified, if desired, by changing the values of the resistors. Capacitor C2 is a timing element, the value of which is adjusted for the magnitude of the signal and reference channels. The current through each photodiode is a function of the intensity or power of incident light entering it, as represented by the equation I=RP, where - I=current
- R=responsivity (Amp/Watt) and
- P=light power in watts.
- In the fluorescence embodiment, the incident light power impinging upon the photodiode detectors changes with analyte concentration.
-
FIG. 10 is a timing diagram showing the voltage levels of theterminals comparator 904. At the cycle start, the voltage level ofoutput terminal 904 c is at ground (low output state), the voltage level of capacitor C2 (which corresponds to the voltage level atinput terminal 904 b) is at ⅔ Vss, and the voltage level ofinput terminal 904 a is at ⅓ Vss. In this instance,photodiode 901 is forward-biased andphotodiode 902 is reverse-biased. The voltage drop across the forward-biasedphotodiode 901 is simply its threshold voltage, while the reverse-biasedphotodiode 902 exhibits a current flow proportional to the incident light impinging upon it. This current discharges the capacitor C2 at a rate of dV/dt=I902/C2, until it reaches a voltage level of ⅓ Vss as shown inFIG. 10 . Inserting the above equation for photodiode current results in the equation dV/dt=RP/C2. Solving for P, P=(dV*C2)/(dt*R), where - dV=difference between comparator trigger points (in the example ⅓ Vss)
- C2=value of capacitor C2 in farads
- dt=time to charge or discharge (as measured by the external unit) and
- R=responsivity (in amps/watts) of the photodetector
- At this time, the
comparator 904 switches to a high output state Vss onoutput terminal 904 c. The trigger point (input terminal 904 a) is now at ⅔ Vss, and the polarity of thephotodiodes photodiode 901 is now reverse-biased andphotodiode 902 is now forward-biased. -
Photodiode 901 now controls the charging of capacitor C2 at a rate of dV/dt=I901/C2 until the voltage of capacitor C2 reaches ⅔ Vss. When the voltage across capacitor C2 reaches ⅔ Vss, the output of thecomparator 904 again switches to the low output state. So long as the system is powered and incident light is present on the photodiodes, the cycle will continue to repeat as shown inFIG. 10 . - If the incident light intensity on each
photodiode detector FIG. 10 , wherein the capacitor charge current is higher than the capacitor discharge current. Because the same capacitor is charged and discharged, the different charge and discharge times are a function only of the difference between the incident light levels on the two photodiode detectors. Consequently, the duty cycle of the squarewave produced by thecomparator 904 is indicative of changes between incident light on the signal channel photodiode and incident light on the reference channel photodiode. Suitable algorithms for taking into account changes in duty cycle of the squarewave from the comparator in determining analyte concentration are generally known in the art (see prior art references discussed supra) and will not be further discussed herein. - Once the squarewave is established, it must be transferred to the external unit. This is done by loading the
internal coil 908, and then detecting the change in load on the external coil inductively coupled to the internal coil. The loading is provided byresistor 910, which is connected to theoutput terminal 904 c of thecomparator 904. When the comparator is in a high output state, an additional current Vss/R910 is drawn from thevoltage regulator 909. When the comparator is in a low output state, this additional current is not present. Consequently,resistor 910 acts as a load that is switched into and out of the circuit at a rate determined by the concentration of analyte and the output of the reference channel. Because the current throughresistor 910 is provided by the internal tuned tankcircuit including coil 908, the switching of the resistor load also switches the load on the tank includinginternal coil 908. The change in impedance of the tank caused by the changing load is detected by a corresponding change in load on the inductively coupled external coil, as described above. Thevoltage regulator 909 removes any effects caused by coil placement in the field. TheLED 903 emits the excitation light for the indicator molecule sensor. Power for theLED 903 is provided by the voltage regulator. It is important to keep the intensity of the LED constant during an analyte measurement reading. Once the output of the voltage regulator is in regulation, the LED intensity will be constant. The step recovery time of the regulator is very fast, with the transition between loading states being rapid enough to permit differentiation and AC coupling in the external unit. - As also will be recognized, the fluorescence-based sensor embodiments described in
FIGS. 6-8 are just examples to which the disclosed invention may be applied. The present invention may also be applied in a number of other applications such as, for example, an absorbance-based sensor or a refractive-index-based sensor as described in U.S. patent application Ser. No. 09/383,148, filed Aug. 28, 1999, incorporated herein by reference. - The invention having been thus described, it will be apparent to those skilled in the art that the same may be varied in many ways without departing from the spirit and scope of the invention. For example, while the invention has been described with reference to an analog circuit, the principles of the invention may be carried out equivalently through the use of an appropriately programmed digital signal processor. Any and all such modifications are intended to be encompassed by the following claims.
Claims (25)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/836,085 US20180098699A1 (en) | 2000-06-29 | 2017-12-08 | Implanted sensor processing system and method for processing implanted sensor output |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/605,706 US6400974B1 (en) | 2000-06-29 | 2000-06-29 | Implanted sensor processing system and method for processing implanted sensor output |
US10/332,619 US7553280B2 (en) | 2000-06-29 | 2001-06-27 | Implanted sensor processing system and method |
PCT/US2001/020390 WO2002002005A1 (en) | 2000-06-29 | 2001-06-27 | Implanted sensor processing system and method |
US12/493,478 US20090264718A1 (en) | 2000-06-29 | 2009-06-29 | Implanted sensor processing system and method for processing implanted sensor output |
US15/456,980 US20170181632A1 (en) | 2000-06-29 | 2017-03-13 | Implanted sensor processing system and method for processing implanted sensor output |
US15/836,085 US20180098699A1 (en) | 2000-06-29 | 2017-12-08 | Implanted sensor processing system and method for processing implanted sensor output |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/456,980 Continuation US20170181632A1 (en) | 2000-06-29 | 2017-03-13 | Implanted sensor processing system and method for processing implanted sensor output |
Publications (1)
Publication Number | Publication Date |
---|---|
US20180098699A1 true US20180098699A1 (en) | 2018-04-12 |
Family
ID=31993722
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/332,619 Expired - Fee Related US7553280B2 (en) | 2000-06-29 | 2001-06-27 | Implanted sensor processing system and method |
US12/493,478 Abandoned US20090264718A1 (en) | 2000-06-29 | 2009-06-29 | Implanted sensor processing system and method for processing implanted sensor output |
US15/456,980 Abandoned US20170181632A1 (en) | 2000-06-29 | 2017-03-13 | Implanted sensor processing system and method for processing implanted sensor output |
US15/836,085 Abandoned US20180098699A1 (en) | 2000-06-29 | 2017-12-08 | Implanted sensor processing system and method for processing implanted sensor output |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/332,619 Expired - Fee Related US7553280B2 (en) | 2000-06-29 | 2001-06-27 | Implanted sensor processing system and method |
US12/493,478 Abandoned US20090264718A1 (en) | 2000-06-29 | 2009-06-29 | Implanted sensor processing system and method for processing implanted sensor output |
US15/456,980 Abandoned US20170181632A1 (en) | 2000-06-29 | 2017-03-13 | Implanted sensor processing system and method for processing implanted sensor output |
Country Status (1)
Country | Link |
---|---|
US (4) | US7553280B2 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6675049B2 (en) * | 2001-07-17 | 2004-01-06 | Medtronic, Inc. | Method and apparatus for automatic implantable medical lead recognition and configuration |
CA2516497A1 (en) * | 2003-02-19 | 2004-09-02 | Sicel Technologies Inc. | In vivo fluorescence sensors, systems, and related methods operating in conjunction with fluorescent analytes |
CN1781151B (en) * | 2003-04-29 | 2010-09-01 | 皇家飞利浦电子股份有限公司 | System for copy protection of an information carrier |
NZ528542A (en) * | 2003-09-29 | 2006-09-29 | Auckland Uniservices Ltd | Inductively-powered power transfer system with one or more, independently controlled loads |
US7450980B2 (en) * | 2004-03-31 | 2008-11-11 | Terumo Kabushiki Kaisha | Intracorporeal substance measuring assembly |
US7545272B2 (en) | 2005-02-08 | 2009-06-09 | Therasense, Inc. | RF tag on test strips, test strip vials and boxes |
US20060241397A1 (en) * | 2005-02-22 | 2006-10-26 | Assaf Govari | Reference pad for position sensing |
US7808253B2 (en) * | 2005-12-02 | 2010-10-05 | Semiconductor Energy Laboratory Co., Ltd. | Test method of microstructure body and micromachine |
DE102007003341B4 (en) * | 2007-01-17 | 2018-01-04 | Eyesense Ag | Eyepiece sensor and measuring system for detecting an analyte in an eye fluid |
JP5188880B2 (en) * | 2008-05-26 | 2013-04-24 | オリンパスメディカルシステムズ株式会社 | Capsule type medical device and method for charging capsule type medical device |
US8264240B2 (en) | 2008-07-20 | 2012-09-11 | Cardiomems, Inc. | Physical property sensor with active electronic circuit and wireless power and data transmission |
WO2012034110A2 (en) * | 2010-09-10 | 2012-03-15 | Fibralign Corp. | Biodegradable multilayer constructs |
CN103619255B (en) * | 2011-02-28 | 2016-11-02 | 雅培糖尿病护理公司 | The device that associates with analyte monitoring device, system and method and combine their device |
CN103533884B (en) | 2011-03-15 | 2016-06-01 | 传感技术股份有限公司 | The integrated catalytic protection of oxidation sensitive material |
AU2012322673A1 (en) * | 2011-10-11 | 2014-05-29 | Senseonics, Incorporated | Electrodynamic field strength triggering system |
US10660542B2 (en) * | 2013-01-26 | 2020-05-26 | Cianna Medical, Inc. | RFID markers and systems and methods for identifying and locating them |
WO2014205205A1 (en) | 2013-06-19 | 2014-12-24 | Senseonics, Incorporated | A remotely powered sensor with antenna location independent of sensing site |
US9963556B2 (en) | 2013-09-18 | 2018-05-08 | Senseonics, Incorporated | Critical point drying of hydrogels in analyte sensors |
EP3076550A1 (en) * | 2015-03-30 | 2016-10-05 | ALSTOM Technology Ltd | Circuit and a method for the galvanically isolated control of a semiconductor switch |
DE102015108644A1 (en) * | 2015-06-01 | 2016-12-01 | Biotronik Se & Co. Kg | Cross sensitivity compensated biosensor |
WO2017151808A1 (en) | 2016-03-03 | 2017-09-08 | Cianna Medical, Inc. | Implantable markers, and systems and methods for using them |
US11883150B2 (en) | 2018-09-06 | 2024-01-30 | Cianna Medical, Inc. | Systems for identifying and locating reflectors using orthogonal sequences of reflector switching |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4571589A (en) * | 1982-11-22 | 1986-02-18 | Cordis Corporation | Biomedical implant with high speed, low power two-way telemetry |
US5713939A (en) * | 1996-09-16 | 1998-02-03 | Sulzer Intermedics Inc. | Data communication system for control of transcutaneous energy transmission to an implantable medical device |
US5833603A (en) * | 1996-03-13 | 1998-11-10 | Lipomatrix, Inc. | Implantable biosensing transponder |
US6175752B1 (en) * | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
US6304766B1 (en) * | 1998-08-26 | 2001-10-16 | Sensors For Medicine And Science | Optical-based sensing devices, especially for in-situ sensing in humans |
US6464687B1 (en) * | 1999-03-09 | 2002-10-15 | Ball Semiconductor, Inc. | Implantable drug delivery system |
US6546268B1 (en) * | 1999-06-02 | 2003-04-08 | Ball Semiconductor, Inc. | Glucose sensor |
Family Cites Families (116)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS36022343B1 (en) * | 1959-12-24 | 1961-11-18 | Univ Tokyo | |
US3576554A (en) * | 1967-11-30 | 1971-04-27 | Fairchild Hiller Corp | Passive telemetry system |
GB1365553A (en) * | 1971-06-24 | 1974-09-04 | Foseco Int | Ingot mould head boxes |
US3872455A (en) * | 1971-11-17 | 1975-03-18 | Monitron Ind | Physiological measurement display system |
US3800300A (en) * | 1971-12-23 | 1974-03-26 | Ball Corp | Condition responsive signal producing device |
US3853117A (en) * | 1972-05-15 | 1974-12-10 | Berkeley Bio Eng Inc | Pressure sensing system and method |
US3949388A (en) * | 1972-11-13 | 1976-04-06 | Monitron Industries, Inc. | Physiological sensor and transmitter |
US3921621A (en) * | 1973-08-23 | 1975-11-25 | Lee R Baessler | Method and system utilizing a disposable transmitter for monitoring a patient{3 s condition |
SE406551B (en) * | 1974-05-07 | 1979-02-19 | Seiko Instr & Electronics | SYSTEM FOR DETECTING INFORMATION REGARDING THE ELECTROMOTOR POWER OF SERIES-PLACED BATTERIES IN A HEART STIMULATOR |
US3972320A (en) * | 1974-08-12 | 1976-08-03 | Gabor Ujhelyi Kalman | Patient monitoring system |
GB1543155A (en) * | 1975-05-02 | 1979-03-28 | Nat Res Dev | Transponders |
US4186749A (en) * | 1977-05-12 | 1980-02-05 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Induction powered biological radiosonde |
US4494545A (en) * | 1980-05-27 | 1985-01-22 | Cordis Corporation | Implant telemetry system |
US4361153A (en) * | 1980-05-27 | 1982-11-30 | Cordis Corporation | Implant telemetry system |
US4681111A (en) * | 1985-04-05 | 1987-07-21 | Siemens-Pacesetter, Inc. | Analog and digital telemetry system for an implantable device |
US5001054A (en) * | 1986-06-26 | 1991-03-19 | Becton, Dickinson And Company | Method for monitoring glucose |
US4861163A (en) * | 1988-01-06 | 1989-08-29 | Amoco Corporation | Ellipsoidal cylinder fluorescence analyzer |
US5024224A (en) * | 1988-09-01 | 1991-06-18 | Storz Instrument Company | Method of readout of implanted hearing aid device and apparatus therefor |
US5218207A (en) * | 1989-01-19 | 1993-06-08 | Futrex, Inc. | Using led harmonic wavelengths for near-infrared quantitative |
JP2910858B2 (en) | 1989-08-31 | 1999-06-23 | 富士重工業株式会社 | Engine knock detection method |
US6040194A (en) * | 1989-12-14 | 2000-03-21 | Sensor Technologies, Inc. | Methods and device for detecting and quantifying substances in body fluids |
US5244810A (en) * | 1990-01-12 | 1993-09-14 | Gottlieb Amos J | Analytical method |
DE69102470T2 (en) * | 1990-04-05 | 1995-01-26 | Nippon Denso Co | Tire pressure detection device for a vehicle. |
US5117825A (en) * | 1990-11-09 | 1992-06-02 | John Grevious | Closed loop transmitter for medical implant |
US5303026A (en) * | 1991-02-26 | 1994-04-12 | The Regents Of The University Of California Los Alamos National Laboratory | Apparatus and method for spectroscopic analysis of scattering media |
NL9200207A (en) * | 1992-02-05 | 1993-09-01 | Nedap Nv | IMPLANTABLE BIOMEDICAL SENSOR DEVICE, IN PARTICULAR FOR MEASUREMENT OF THE GLUCOSE CONCENTRATION. |
US5341805A (en) * | 1993-04-06 | 1994-08-30 | Cedars-Sinai Medical Center | Glucose fluorescence monitor and method |
US5314457A (en) * | 1993-04-08 | 1994-05-24 | Jeutter Dean C | Regenerative electrical |
US5571148A (en) * | 1994-08-10 | 1996-11-05 | Loeb; Gerald E. | Implantable multichannel stimulator |
US5630836A (en) | 1995-01-19 | 1997-05-20 | Vascor, Inc. | Transcutaneous energy and information transmission apparatus |
US5517313A (en) * | 1995-02-21 | 1996-05-14 | Colvin, Jr.; Arthur E. | Fluorescent optical sensor |
US5584870A (en) | 1995-03-09 | 1996-12-17 | Cochlear Ltd. | Implant ESD protection network |
NL1000369C2 (en) | 1995-05-16 | 1996-11-19 | Idento Electronics Bv | Measuring device for wireless temperature measurement. |
US5628310A (en) * | 1995-05-19 | 1997-05-13 | Joseph R. Lakowicz | Method and apparatus to perform trans-cutaneous analyte monitoring |
US5995860A (en) * | 1995-07-06 | 1999-11-30 | Thomas Jefferson University | Implantable sensor and system for measurement and control of blood constituent levels |
US6002954A (en) * | 1995-11-22 | 1999-12-14 | The Regents Of The University Of California | Detection of biological molecules using boronate-based chemical amplification and optical sensors |
US5704352A (en) * | 1995-11-22 | 1998-01-06 | Tremblay; Gerald F. | Implantable passive bio-sensor |
WO1997032629A1 (en) * | 1996-03-06 | 1997-09-12 | Advanced Bionics Corporation | Magnetless implantable stimulator and external transmitter and implant tools for aligning same |
EP0923335B1 (en) * | 1996-07-08 | 2006-08-23 | Animas Corporation | Implantable sensor and system for in vivo measurement and control of fluid constituent levels |
US5630838A (en) * | 1996-07-19 | 1997-05-20 | Sulzer Intermedics, Inc. | Muscle stimulation electrode for implantable cardiac stimulation device with warning system |
SG54559A1 (en) * | 1996-09-13 | 1998-11-16 | Hitachi Ltd | Power transmission system ic card and information communication system using ic card |
JPH1090405A (en) * | 1996-09-19 | 1998-04-10 | Toshiba Corp | Information processor |
US5963132A (en) * | 1996-10-11 | 1999-10-05 | Avid Indentification Systems, Inc. | Encapsulated implantable transponder |
US5735887A (en) * | 1996-12-10 | 1998-04-07 | Exonix Corporation | Closed-loop, RF-coupled implanted medical device |
NO311817B1 (en) * | 1996-12-23 | 2002-01-28 | Lifecare As | Method for recording the changes in the level of an osmotically active component in body fluid and device for carrying out the method |
US6164284A (en) * | 1997-02-26 | 2000-12-26 | Schulman; Joseph H. | System of implantable devices for monitoring and/or affecting body parameters |
US6419624B1 (en) * | 1999-10-11 | 2002-07-16 | Uromedica, Inc. | Apparatus and method for inserting an adjustable implantable genitourinary device |
US5984875A (en) * | 1997-08-22 | 1999-11-16 | Innotek Pet Products, Inc. | Ingestible animal temperature sensor |
US6731976B2 (en) * | 1997-09-03 | 2004-05-04 | Medtronic, Inc. | Device and method to measure and communicate body parameters |
US6259937B1 (en) * | 1997-09-12 | 2001-07-10 | Alfred E. Mann Foundation | Implantable substrate sensor |
EP1029229A1 (en) * | 1997-09-30 | 2000-08-23 | M- Biotech, Inc. | Biosensor |
US5967986A (en) * | 1997-11-25 | 1999-10-19 | Vascusense, Inc. | Endoluminal implant with fluid flow sensing capability |
US6585763B1 (en) * | 1997-10-14 | 2003-07-01 | Vascusense, Inc. | Implantable therapeutic device and method |
US6231516B1 (en) * | 1997-10-14 | 2001-05-15 | Vacusense, Inc. | Endoluminal implant with therapeutic and diagnostic capability |
US6088608A (en) * | 1997-10-20 | 2000-07-11 | Alfred E. Mann Foundation | Electrochemical sensor and integrity tests therefor |
US6289229B1 (en) * | 1998-01-20 | 2001-09-11 | Scimed Life Systems, Inc. | Readable probe array for in vivo use |
US6009878A (en) * | 1998-02-02 | 2000-01-04 | Medtronic, Inc. | System for locating implantable medical device |
US6058330A (en) * | 1998-03-06 | 2000-05-02 | Dew Engineering And Development Limited | Transcutaneous energy transfer device |
DE19811017A1 (en) * | 1998-03-13 | 1999-09-16 | Dade Behring Marburg Gmbh | New method for the determination of plasma proteins and factors of hemostasis as well as a new, implantable measuring device |
GB2335496B (en) * | 1998-03-20 | 2000-06-07 | David Eglise | Sensing devices & systems |
US6505059B1 (en) * | 1998-04-06 | 2003-01-07 | The General Hospital Corporation | Non-invasive tissue glucose level monitoring |
CA2332112C (en) * | 1998-05-13 | 2004-02-10 | Cygnus, Inc. | Monitoring of physiological analytes |
CN102226766B (en) * | 1998-08-26 | 2017-03-01 | 医药及科学传感器公司 | Based on optical sensing device further |
US6212431B1 (en) * | 1998-09-08 | 2001-04-03 | Advanced Bionics Corporation | Power transfer circuit for implanted devices |
US6201980B1 (en) * | 1998-10-05 | 2001-03-13 | The Regents Of The University Of California | Implantable medical sensor system |
EP2229879A1 (en) * | 1998-10-08 | 2010-09-22 | Medtronic MiniMed, Inc. | Telemetered characteristic monitor system |
US6073050A (en) * | 1998-11-10 | 2000-06-06 | Advanced Bionics Corporation | Efficient integrated RF telemetry transmitter for use with implantable device |
AU2400200A (en) * | 1998-12-31 | 2000-07-31 | Ball Semiconductor Inc. | Miniature implanted orthopedic sensors |
US6067463A (en) * | 1999-01-05 | 2000-05-23 | Abbott Laboratories | Method and apparatus for non-invasively measuring the amount of glucose in blood |
AU2491300A (en) * | 1999-01-06 | 2000-07-24 | Ball Semiconductor Inc. | Wireless ekg |
US6424847B1 (en) * | 1999-02-25 | 2002-07-23 | Medtronic Minimed, Inc. | Glucose monitor calibration methods |
US6092530A (en) | 1999-03-24 | 2000-07-25 | The B.F. Goodrich Company | Remotely interrogated implant device with sensor for detecting accretion of biological matter |
US6206835B1 (en) * | 1999-03-24 | 2001-03-27 | The B. F. Goodrich Company | Remotely interrogated diagnostic implant device with electrically passive sensor |
US6475750B1 (en) * | 1999-05-11 | 2002-11-05 | M-Biotech, Inc. | Glucose biosensor |
US6607485B2 (en) * | 1999-06-03 | 2003-08-19 | Cardiac Intelligence Corporation | Computer readable storage medium containing code for automated collection and analysis of patient information retrieved from an implantable medical device for remote patient care |
US6802811B1 (en) * | 1999-09-17 | 2004-10-12 | Endoluminal Therapeutics, Inc. | Sensing, interrogating, storing, telemetering and responding medical implants |
US6368275B1 (en) * | 1999-10-07 | 2002-04-09 | Acuson Corporation | Method and apparatus for diagnostic medical information gathering, hyperthermia treatment, or directed gene therapy |
US6442434B1 (en) * | 1999-10-19 | 2002-08-27 | Abiomed, Inc. | Methods and apparatus for providing a sufficiently stable power to a load in an energy transfer system |
US6411108B1 (en) * | 1999-11-05 | 2002-06-25 | Sensor Technologies, Inc. | Noncontact signal analyzer |
FR2802738A1 (en) * | 1999-12-15 | 2001-06-22 | Circe | TRANSPONDER READING DEVICE |
US6415186B1 (en) * | 2000-01-14 | 2002-07-02 | Advanced Bionics Corporation | Active feed forward power control loop |
US20020016535A1 (en) * | 2000-01-28 | 2002-02-07 | Martin W. Blake | Subcutaneous glucose measurement device |
US6895263B2 (en) * | 2000-02-23 | 2005-05-17 | Medtronic Minimed, Inc. | Real time self-adjusting calibration algorithm |
DE10011284B4 (en) * | 2000-03-08 | 2007-06-28 | Disetronic Licensing Ag | Apparatus for in vivo measurement of the concentration of an ingredient of a body fluid |
US7006858B2 (en) * | 2000-05-15 | 2006-02-28 | Silver James H | Implantable, retrievable sensors and immunosensors |
IL143418A (en) * | 2000-05-31 | 2004-09-27 | Given Imaging Ltd | Measurement of electrical characteristics of tissue |
AU2001268613A1 (en) * | 2000-06-20 | 2002-01-02 | Bruce H. Levin | Tracking surgical implements with integrated circuits |
JP2004501380A (en) * | 2000-06-26 | 2004-01-15 | ボストン メディカル テクノロジーズ インコーポレイテッド | Glucose measurement system |
US6400974B1 (en) * | 2000-06-29 | 2002-06-04 | Sensors For Medicine And Science, Inc. | Implanted sensor processing system and method for processing implanted sensor output |
US20030169169A1 (en) * | 2000-08-17 | 2003-09-11 | Luc Wuidart | Antenna generating an electromagnetic field for transponder |
US6553244B2 (en) * | 2000-08-18 | 2003-04-22 | Cygnus, Inc. | Analyte monitoring device alarm augmentation system |
US6443891B1 (en) * | 2000-09-20 | 2002-09-03 | Medtronic, Inc. | Telemetry modulation protocol system for medical devices |
GB0025147D0 (en) | 2000-10-13 | 2000-11-29 | Torsana Diabetes Diagnostics A | Optical sensor for in situ measurement of analytes |
US6421015B1 (en) * | 2001-01-02 | 2002-07-16 | Auden Techno Corp | Planar helix antenna with two frequencies |
US6666821B2 (en) | 2001-01-08 | 2003-12-23 | Medtronic, Inc. | Sensor system |
US6542777B1 (en) * | 2001-01-19 | 2003-04-01 | Advanced Bionics Corporation | Spiral shield for a flexible high-Q implantable inductively coupled device |
US6454710B1 (en) * | 2001-04-11 | 2002-09-24 | Motorola, Inc. | Devices and methods for monitoring an analyte |
US6694158B2 (en) * | 2001-04-11 | 2004-02-17 | Motorola, Inc. | System using a portable detection device for detection of an analyte through body tissue |
US6456256B1 (en) * | 2001-08-03 | 2002-09-24 | Cardiac Pacemakers, Inc. | Circumferential antenna for an implantable medical device |
US7323141B2 (en) * | 2001-08-13 | 2008-01-29 | Bayer Healthcare Llc | Button layout for a testing instrument |
JP3962250B2 (en) * | 2001-08-29 | 2007-08-22 | 株式会社レアメタル | In vivo information detection system and tag device and relay device used therefor |
US6545483B1 (en) * | 2001-08-29 | 2003-04-08 | Sensor Technologies, Inc. | Analyzer sensor |
US6809507B2 (en) * | 2001-10-23 | 2004-10-26 | Medtronic Minimed, Inc. | Implantable sensor electrodes and electronic circuitry |
US6731961B2 (en) * | 2001-11-09 | 2004-05-04 | Optiscan Biomedical Corp. | Method for transforming phase spectra to absorption spectra |
US6682490B2 (en) * | 2001-12-03 | 2004-01-27 | The Cleveland Clinic Foundation | Apparatus and method for monitoring a condition inside a body cavity |
US20030113934A1 (en) * | 2001-12-17 | 2003-06-19 | Sung-Yun Kwon | Diagnostic sensing apparatus |
US7022072B2 (en) * | 2001-12-27 | 2006-04-04 | Medtronic Minimed, Inc. | System for monitoring physiological characteristics |
US7050855B2 (en) * | 2002-01-29 | 2006-05-23 | Medtronic, Inc. | Medical implantable system for reducing magnetic resonance effects |
US6806552B2 (en) * | 2002-02-21 | 2004-10-19 | Altera, Corp. | Integrated inductive circuits |
US6957107B2 (en) * | 2002-03-13 | 2005-10-18 | Cardionet, Inc. | Method and apparatus for monitoring and communicating with an implanted medical device |
US7485093B2 (en) * | 2002-04-25 | 2009-02-03 | Given Imaging Ltd. | Device and method for in-vivo sensing |
US7445010B2 (en) * | 2003-01-29 | 2008-11-04 | Torax Medical, Inc. | Use of magnetic implants to treat issue structures |
JP2003325439A (en) * | 2002-05-15 | 2003-11-18 | Olympus Optical Co Ltd | Capsule type medical treatment device |
US6772011B2 (en) * | 2002-08-20 | 2004-08-03 | Thoratec Corporation | Transmission of information from an implanted medical device |
US7134999B2 (en) | 2003-04-04 | 2006-11-14 | Dexcom, Inc. | Optimized sensor geometry for an implantable glucose sensor |
US20140257141A1 (en) * | 2013-03-05 | 2014-09-11 | Great Lakes Neurotechnologies Inc. | Movement disorder monitoring and symptom quantification system and method |
-
2001
- 2001-06-27 US US10/332,619 patent/US7553280B2/en not_active Expired - Fee Related
-
2009
- 2009-06-29 US US12/493,478 patent/US20090264718A1/en not_active Abandoned
-
2017
- 2017-03-13 US US15/456,980 patent/US20170181632A1/en not_active Abandoned
- 2017-12-08 US US15/836,085 patent/US20180098699A1/en not_active Abandoned
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4571589A (en) * | 1982-11-22 | 1986-02-18 | Cordis Corporation | Biomedical implant with high speed, low power two-way telemetry |
US5833603A (en) * | 1996-03-13 | 1998-11-10 | Lipomatrix, Inc. | Implantable biosensing transponder |
US5713939A (en) * | 1996-09-16 | 1998-02-03 | Sulzer Intermedics Inc. | Data communication system for control of transcutaneous energy transmission to an implantable medical device |
US6175752B1 (en) * | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
US6304766B1 (en) * | 1998-08-26 | 2001-10-16 | Sensors For Medicine And Science | Optical-based sensing devices, especially for in-situ sensing in humans |
US6464687B1 (en) * | 1999-03-09 | 2002-10-15 | Ball Semiconductor, Inc. | Implantable drug delivery system |
US6546268B1 (en) * | 1999-06-02 | 2003-04-08 | Ball Semiconductor, Inc. | Glucose sensor |
Also Published As
Publication number | Publication date |
---|---|
US7553280B2 (en) | 2009-06-30 |
US20090264718A1 (en) | 2009-10-22 |
US20170181632A1 (en) | 2017-06-29 |
US20040054385A1 (en) | 2004-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20180098699A1 (en) | Implanted sensor processing system and method for processing implanted sensor output | |
EP2103250B1 (en) | Implanted sensor processing system | |
AU2002216747A1 (en) | Implanted sensor processing system and method | |
EP1108207B1 (en) | Optical-based sensing devices | |
US7800078B2 (en) | Printed circuit board with integrated antenna and implantable sensor processing system with integrated printed circuit board antenna | |
AU2004201752B2 (en) | Optical-based sensing devices |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: OXFORD FINANCE LLC, AS COLLATERAL AGENT AND AS LENDER, VIRGINIA Free format text: SECURITY INTEREST;ASSIGNOR:SENSEONICS, INCORPORATED;REEL/FRAME:045164/0154 Effective date: 20180125 Owner name: OXFORD FINANCE LLC, AS COLLATERAL AGENT AND AS LEN Free format text: SECURITY INTEREST;ASSIGNOR:SENSEONICS, INCORPORATED;REEL/FRAME:045164/0154 Effective date: 20180125 |
|
AS | Assignment |
Owner name: SENSEONICS, INCORPORATED, MAINE Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:LESHO, JEFFERY C.;REEL/FRAME:045141/0092 Effective date: 20180227 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
AS | Assignment |
Owner name: SENSEONICS, INCORPORATED, MARYLAND Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:OXFORD FINANCE LLC, AS COLLATERAL AGENT AND AS LENDER;REEL/FRAME:049873/0713 Effective date: 20190725 |
|
AS | Assignment |
Owner name: SOLAR CAPITAL LTD., AS AGENT, NEW YORK Free format text: INTELLECTUAL PROPERTY SECURITY AGREEMENT;ASSIGNOR:SENSEONICS, INCORPORATED;REEL/FRAME:049926/0827 Effective date: 20190725 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
AS | Assignment |
Owner name: SENSEONICS, INCORPORATED, MARYLAND Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:SOLAR CAPITAL LTD., AS AGENT;REEL/FRAME:052207/0242 Effective date: 20200323 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
AS | Assignment |
Owner name: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT, DELAWARE Free format text: INTELLECTUAL PROPERTY SECURITY AGREEMENT -SECOND LIEN;ASSIGNORS:SENSEONICS, INCORPORATED;SENSEONICS HOLDINGS, INC.;REEL/FRAME:052490/0160 Effective date: 20200424 Owner name: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT, DELAWARE Free format text: INTELLECTUAL PROPERTY SECURITY AGREEMENT - FIRST LIEN;ASSIGNORS:SENSEONICS, INCORPORATED;SENSEONICS HOLDINGS, INC.;REEL/FRAME:052492/0109 Effective date: 20200424 |
|
AS | Assignment |
Owner name: ALTER DOMUS (US) LLC, AS COLLATERAL AGENT, ILLINOIS Free format text: INTELLECTUAL PROPERTY SECURITY AGREEMENT;ASSIGNOR:SENSEONICS, INCORPORATED;REEL/FRAME:053496/0292 Effective date: 20200814 Owner name: SENSEONICS HOLDINGS, INC., MARYLAND Free format text: RELEASE OF SECURITY INTEREST IN PATENTS AND TRADEMARKS;ASSIGNOR:WILMINGTON SAVINGS FUND SOCIETY, FSB, COLLATERAL AGENT;REEL/FRAME:053498/0275 Effective date: 20200814 Owner name: SENSEONICS, INCORPORATED, MARYLAND Free format text: RELEASE OF SECURITY INTEREST IN PATENTS AND TRADEMARKS;ASSIGNOR:WILMINGTON SAVINGS FUND SOCIETY, FSB, COLLATERAL AGENT;REEL/FRAME:053498/0275 Effective date: 20200814 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: SENSEONICS, INCORPORATED, MARYLAND Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:ALTER DOMUS (US) LLC, AS COLLATERAL AGENT;REEL/FRAME:063338/0890 Effective date: 20230412 Owner name: SENSEONICS HOLDINGS, INC., MARYLAND Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:ALTER DOMUS (US) LLC, AS COLLATERAL AGENT;REEL/FRAME:063338/0890 Effective date: 20230412 |
|
AS | Assignment |
Owner name: SENSEONICS HOLDINGS, INC., MARYLAND Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT;REEL/FRAME:064834/0962 Effective date: 20230907 Owner name: SENSEONICS, INCORPORATED, MARYLAND Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT;REEL/FRAME:064834/0962 Effective date: 20230907 |
|
AS | Assignment |
Owner name: HERCULES CAPITAL, INC., CALIFORNIA Free format text: SECURITY INTEREST;ASSIGNOR:SENSEONICS, INCORPORATED;REEL/FRAME:064866/0963 Effective date: 20230908 |